Surgery – Respiratory method or device – Means for mixing treating agent with respiratory gas
Patent
1994-12-09
1999-02-23
Lewis, Aaron J.
Surgery
Respiratory method or device
Means for mixing treating agent with respiratory gas
12820014, 12820024, A61M 1500
Patent
active
058733590
ABSTRACT:
A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide or a therapeutically-effective amount of a nitric oxide-releasing compound, and an inhaler device containing nitric oxide gas and/or a nitric oxide-releasing compound.
REFERENCES:
patent: 3745991 (1973-07-01), Gauthier et al.
patent: 3785377 (1974-01-01), Jorgensen
patent: 4010897 (1977-03-01), Treharne et al.
patent: 4287040 (1981-09-01), Alamaro
patent: 4297123 (1981-10-01), Wyse et al.
patent: 4336798 (1982-06-01), Beran
patent: 4484577 (1984-11-01), Sackner et al.
patent: 4534343 (1985-08-01), Nowacki et al.
patent: 4592348 (1986-06-01), Waters et al.
patent: 4667668 (1987-05-01), Wetterlin
patent: 4852561 (1989-08-01), Sperry
patent: 4877589 (1989-10-01), O'Hare
patent: 4915915 (1990-04-01), Treharne et al.
patent: 4954526 (1990-09-01), Keefer
patent: 5007419 (1991-04-01), Weinstein et al.
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5178138 (1993-01-01), Walstrom et al.
patent: 5187305 (1993-02-01), Thompson et al.
patent: 5208233 (1993-05-01), Keefer et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5396882 (1995-03-01), Zapol
patent: 5427797 (1995-06-01), Frostell et al.
patent: 5485827 (1996-01-01), Zapol et al.
Blomqvist et al., Inhaled Nitric Oxide (NO): A Selective Pulmonary Vasodilator Reversing Human Hypoxic Pulmonary Vasoconstriction (HPV), Circulation 84:361, 1991.
Desai et al, Involvement of Nitric Oxide in the Relfex Relaxation of the Stomach to Accomodate food or Fluid, Nature 351:477, 1991.
Donahoe et al., Production of O.sub.3, NO, and N.sub.2 O in a Pulsed Discharge at 1 Atm, Ind. Eng. Chem. 16:208-215, 1977.
Fractacci et al., Inhaled Nitric Oxide, Anesthesiology 75:990-999, 1991.
Pepke-Zaba et al., Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilation in Pulmonary Hypertension, The Lancet 338:1173-1174, 1991.
Rimar et al., Prolonged Duration of Inhaled Nitric Oxide Induced Vasodilation in Perfused Rabbit Lungs Circulation 84:362, 1991.
Roberts, Jr. et al., Inhaled Nitric Oxide (NO): A Selective Pulmonary Vasodilator for the Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN), Circulation 84:1279, 1991.
Dupuy et al., Bronchodilator Action of Inhaled Nitric Oxide in Guinea Pigs, J. clin. Invest. 90:421-428, 1992.
Dalby et al., Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions, Pharmac. Re. 5:36-39, 1988.
Buga et al., Endothelium-Derived Nitric Oxide Relaxes Nonvascular Smooth Muscle, European J. of Pharmc. 161:61-72, 1989.
Ishii et al., A Simple and Sensitive Bioassay Method for Detection of EDRF with RFL-6 Rat Lung Fibroblasts, Am. J. Physiol. 261:H598-H603, 1991.
Stuart-Smith et al., Epithelium, contractile Tone, and Responses to Relaxing Agonists in Canine Bronchi, J. Appl. Physiol. 69:678-685, 1990.
Suzuki et al., The Relationship Between Tissue Levels of Cyclic GMP and Tracheal Smooth Muscle Relaxation in the Guinea-Pig, Clinical & Pharmacol. & Physol. 13:39-46, 1986.
Maron et al., Cigarette Smoke Causes Acute Fluctuations in the Cyclic GMP Content of the Isolated Intact Lung, Respiration 43:39-44, 1984.
Heaslip et al., Co-Regulation of Tracheal Tone By Cyclic AMP- and Cyclic GMP-Dependent Mechanisms, J. Pharmacl. & Experms. 243:1018-1026, 1987.
Gilman et al., Vascular Effects of Cigarette Smoke in Isolated Pig Lungs, Am. Rev. Respir. Dis. 124:549-533, 1981.
Flenley, Today's Treatment of Airway Obstruction . . . and Tomorrow's?, Respiration 55:4-9, 1989.
Physician's Desk Reference, pp. 969-971, 2322-2323, 668-670.
Edwards et al., Activation of Hepatic Guanylate Cyclase by Nitrosyl-Heme Complexes, Biomed. Pharmlgy. 30:2531-2538, 1981.
Garg et al., Nitric Oxide Generating Vasodilators Inhibit Mitogenesis and Proliferation of BALB/C 3T3 Fibroblasts by a Cyclic GMP-Independent Mechanism, Biochem. Biophysl. Re. Comm. 171:474-479, 1990.
Schmidt et al., Stimulation of Soluble Coronary Arterial Guanylate Cyclase by Sin-1, European J. Pharmaclgy. 122:75-79, 1986.
McNamara et al., Adenosine 3', 5' Monophosphate Formation by Preparations of Rat Liver Soluble Guanylate Cyclase . . . and Other Nitroso Compounds, Can. J. Physiol. Pharmacol. 58:1446-1456, 1980.
Ignarro, Biosynthesis and Metabolism of Endothelium-Derived Nitric Oxide, Annu. Rev. Pharmacol. Toxicol. 30:535-560, 1990.
Allen and Hanbury, Product Information Bulletin on Ventolin, 1990.
Boje et al., Endothelial Nitric Oxide Generating Enzyme(s) in the Bovine Aorta: Subcellular Location Location and Metabolic Characterization, Am. Soc. Pharmclgy. & Experm. Therapeutics 253:20-26, 1990.
Southern et al., Inhibition of Insulin Secretion by Interleukin-1.beta. and Tumor Necrosis Factor-.alpha. via an L-Arginine-Dependent Nitric Oxide Generating Mechanism, FEBS 276:42-44, 1990.
Garg et al., Nitric Oxide-Generating Vasodilators and 8-Bromo-Cyclic Guanosine Monophosphate Inhibit . . . Vascular Smooth Muscle Cells, J. Clin. Invest. 83:1774-1777, 1989.
Brune et al., Activation of a Cytosolic ADP-Ribosyltransferase by Nitric Oxide-Generating Agents, J. Biol. Chem. 264:8455-8458, 1989.
Curran et al., Nitric Oxide and Nitric Oxide-Generating Compounds Inhibit Hepatocyte Protein Synthesis, FASEB J. 5:2085-2092, 1991.
Ignarro, Endothelium-Derived Nitric Oxide: Actions and Properties, FASEB J. 3:31-36, 1989.
Peckham, Physiologic Factors Affecting Pulmonary Artery Pressure in Infants with Persistent Pulmonary Hypertension, J. Ped. 6:1005-1010, 1978.
Zapol et al., Pulmonary Circulation During Adult Respiratory Distress Syndrome, Mercel Dekker, 241-273, 1985.
Fox et al., Pulmonary Hypertension in the Perinatal Aspiration Syndromes, Pediatrics 59:205-211, 1977.
Dworetz et al., Survival of Infants with Persistent Pulmonary Hypertension without Extracorporeal Membrane Oxygenation, Pediatrics 84:1-6, 1989.
Fishman, Pulmonary Hypertension and Cor Pulmonale, Chapter 64 pp. 999-1048.
Radermacher et al., Comparison of Ketanserin and Sodium Nitroprusside in Patients with Severe ARDS, Anesthesiology 68:152-157, 1988.
Vlahakes et al., The Pathophysiology of Failure in Acute Right Ventricular Hypertension: Hemodynamic and Biochemical Correlations, Circulation 63:87-95, 1981.
Ignarro et al., Endothelium-Derived Relaxing Factor Produced and Released from Artery and Vein is Nitric Oxide, Proc. Natl. Acad. Sci. USA 84:9265-9269, 1987.
Palmer et al., Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor, Nature 327:524-526, 1987.
Higgenbottam et al., Am. Rev. Resp. Dis. Suppl. 137:107, 1988.
Zapol et al., Pulmonary Hypertension in Severe Acute Respiratory Failure, N.E. J. Med. 296:476-480, 1977.
Meyer et al., Nitric Oxide (NO), a New Test Gas for Study of Alveolar-Capillary Diffusion, Eur. Respir. J. 2:494-496, 1989.
Hounam et al., particle Deposition pp. 125-156.
Archer et al., Comparison of the Hemodynamic Effects of Nitric Oxide and Endothelium-Dependent Vasodilators in Intact Lungs, J. Appl. Physiol. 68:735-747, 1990.
Furchgott et al., Endothelium-Derived Relaxing and Contracting Factors, FASEB J. 3:2007-2018, 1989.
Archer et al., Hypoxic Pulmonary Vasoconstriction is Enhanced by Inhibition of the Synthesis of an Endothelium Derived Relaxing Factor, Biochem. Biophysl. Re. Comm. 164:1198-1205, 1989.
Brashers et al., Augmentation of Hypoxic Pulmonary Vasoconstriction in the Isolated Perfused Rat Lung by in Vitro Antagonists of Endothelium-Dependent Relaxation, J. Clin. Invest. 82:1495-1502, 1988.
Ignarro et al., Mechanism of Vascular Smooth Muscle Relaxation by Organic Nitrates, Nitrites, Nitroprusside and Nitric Oxide: . . . S-Nitrosothiols as Active Intermediates, J. Pharmol. Experm. Ther. 218:739-749, 1981.
Kadowitz et al., Pulmonary Vasodilator Responses to Nitroprusside and Nitroglycerin in the Dog, Clin. Invest. 67:893-902, 1981.
Naeije et al., Effects of vasodilators on Hypoxic Pulmonary Vasoconstriction in Normal Man, Chest 82:404-410, 1982.
Flavahan et a
Frostell Claes
Zapol Warren M.
Lewis Aaron J.
The General Hospital Corporation
LandOfFree
Methods and devices for treating pulmonary vasoconstriction and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and devices for treating pulmonary vasoconstriction and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and devices for treating pulmonary vasoconstriction and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-298996